Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Vincristine (1mg) Injection
Therapeutic Category
Anticancer, Oncology
Dosage Form
Injection
Packaging Type
Vial
Packaging
1mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vincept 1 Injection contains Vincristine 1mg, a vinca alkaloid chemotherapeutic agent used for the treatment of various cancers including acute leukemia, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and certain solid tumors. It is administered under strict medical supervision in hospital and oncology care settings.
Vincristine works by inhibiting microtubule formation in cancer cells, preventing cell division and inducing apoptosis. This targeted mechanism helps control the rapid proliferation of malignant cells effectively.
This injection is commonly used as part of combination chemotherapy regimens, allowing oncologists to adjust dosage according to patient-specific treatment protocols. Its intravenous formulation ensures precise delivery and optimal therapeutic efficacy.
Vincept 1 Injection is valued for its clinical reliability and consistent hospital demand, making it an essential product in oncology treatment portfolios. Its role in managing serious cancers supports improved patient outcomes and adherence to established chemotherapy protocols.
Common side effects may include constipation, nausea, vomiting, hair loss, and fatigue. Serious side effects may include peripheral neuropathy, muscle weakness, abdominal pain, bone marrow suppression, and increased risk of infections. Patients should be closely monitored throughout therapy.
Vincept 1 Injection is indicated for the treatment of acute lymphoblastic leukemia, Hodgkin’s and non-Hodgkin’s lymphoma, Wilms’ tumor, neuroblastoma, and other malignancies as prescribed by an oncologist. It is commonly used in multi-drug chemotherapy protocols.
Vincept 1 Injection must be administered only by trained healthcare professionals in a specialized hospital or oncology setting. Intrathecal administration is strictly contraindicated and can be fatal. Dosage must be carefully calculated, and patients should immediately report neurological symptoms or severe constipation.
Store Vincept 1 Injection in a cool, dry place away from direct sunlight. Keep the vial tightly closed and out of reach of children. Do not use if the solution appears discolored or contains particulate matter.
Composition : Telmisartan 20 mg Tablet
Composition : Telmisartan (40mg) Tablet
Composition : Telmisartan (40mg)
Composition : Telmisartan 80mg Tablet
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 6.25mg
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg
Composition : Telmisartan 80mg + Amlodipine 5mg Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) Bilayered
Composition : Telmisartan 40mg + Amlodipine 5mg Tablet
Composition : Telmisartan (80mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Vincept 1 Injection has strong demand in the oncology and critical-care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cancer-care and specialty medicine portfolios.
Medical distributors and agencies can benefit from demand for management of leukemia, lymphoma, breast cancer, lung cancer, and other oncology-related conditions. Vincristine 1mg is an anti-cancer chemotherapy medicine that helps stop or slow the growth of cancer cells The injectable formulation supports hospital-based and oncology treatment protocols This strengthens a reliable oncology and specialty-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vincept 1 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from hospital and oncologist demand, specialty-care market opportunities, institutional supply requirements, reliable supply chain support, and good margins in oncology medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.